PLEASE DO BUSINESS WITH THOSE WHO DO BUSINESS WITH US -- OUR ADVERTISERS.

THANK YOU FOR VISITING OUR WEB PORTAL. PLEASE TELL A FRIEND.

YOU can speak out and be heard by having your own "Column" - Visit the "Public Opinion" Section above.

WE ACKNOWLEDGE AND THANK ALL OUR SOURCES FOR THEIR CONTRIBUTIONS IN MAKING US AMERICA'S NUMBER ONE NEWS INFORMATION PORTAL.

ATTENTION TALK SHOW HOSTS: We are honored that many radio talk show hosts use our Web Portal for their "show prep." We would appreciate your occasional mention of our site to your audience. Thanks!

ADVERTISEMENT: If you want to advertise your business or Web Site, send us an email by clicking on "Contact" above. It could be the best business decision you make.

ABC Online Canada National Post Daily Telegraph The Observer Wired News Xinhua News

VOA VIEW -- Is the opinion of "Voice of Americans", which is a private entity not affiliated in any way with the United States government or any of its agencies. The opinions expressed here, in whatever medium or format, are not necessarily the opinions of the ownership or advertisers of this web site - 0415.

     Go back a decade and most Americans had never heard of Huawei. Today, the Chinese telecom giant is a symbol of how quickly China can dominate a strategic technology sector and in the process create new national security and market threats for U.S. government and industry. China must be put in check. 

     Democratic Senator Mark Warner of Virginia, the top Democrat on the Senate Select Committee on Intelligence, is now worried about another Chinese company that he predicts will eclipse Huawei in both scale and consequence: BGI. It is not building cell towers or smartphones for the 5G era. It is collecting DNA.  “If Huawei was big, BGI will be even bigger,” Warner said at the CNBC CFO Council Summit in Washington, D.C. on Wednesday.

     BGI is one of the largest genomics companies in the world. It operates DNA sequencing laboratories in China and abroad. It processes genetic data for hospitals, pharmaceutical firms and researchers across dozens of countries, according to a recent report by the National Security Commission on Emerging Biotechnology.

     The company began as a Beijing-based research entity, the Beijing Genomics Institute, tied closely to China’s national genome projects. It later expanded into a global commercial powerhouse, selling DNA sequencing, prenatal testing, cancer screening, and large-scale population genetic analysis, according to an NBC News report. Through subsidiaries, BGI says it operates in the U.S. Europe, and Japan. In several countries, it helped built national genetic databases and pandemic testing systems.